Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner
It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, f...
Gespeichert in:
Veröffentlicht in: | The open conference proceedings journal 2010-01, Vol.1, p.54-60 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 60 |
---|---|
container_issue | |
container_start_page | 54 |
container_title | The open conference proceedings journal |
container_volume | 1 |
creator | Orru, Christina D Cannas, MDolores Vascellari, Sarah Abete, Claudia Mandas, Antonella Angius, Fabrizio Cocco, Pierluigi La Colla, Paolo Dessi', Sandra Pani, Alessandra |
description | It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection. |
doi_str_mv | 10.2174/2210289201001010054 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_911150651</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>911150651</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_9111506513</originalsourceid><addsrcrecordid>eNqNTbsKAjEQDKKgqF9gk85KTXJ36pUiPhrhQLGVcOxpJJfVbCz8e3NgYeky7M4MwyxjIymmSi7SmVJSqGWuhBQRcWVpi_Uad9LY7R_eZUOiu4iT5CpP0h47Fzfta12ixasp-fqGFiiAR8v3WANS0GSIr6oKykC88AYd34EDr0NDjeOaH99RXw2F2HDQLooB61TaEgy_t8_G281pvZ88PD5f8cOlNlSCtdoBvuiSSykzMc9k8n_yA0c1TGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>911150651</pqid></control><display><type>article</type><title>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Orru, Christina D ; Cannas, MDolores ; Vascellari, Sarah ; Abete, Claudia ; Mandas, Antonella ; Angius, Fabrizio ; Cocco, Pierluigi ; La Colla, Paolo ; Dessi', Sandra ; Pani, Alessandra</creator><creatorcontrib>Orru, Christina D ; Cannas, MDolores ; Vascellari, Sarah ; Abete, Claudia ; Mandas, Antonella ; Angius, Fabrizio ; Cocco, Pierluigi ; La Colla, Paolo ; Dessi', Sandra ; Pani, Alessandra</creatorcontrib><description>It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection.</description><identifier>ISSN: 2210-2892</identifier><identifier>EISSN: 2210-2892</identifier><identifier>DOI: 10.2174/2210289201001010054</identifier><language>eng</language><ispartof>The open conference proceedings journal, 2010-01, Vol.1, p.54-60</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids></links><search><creatorcontrib>Orru, Christina D</creatorcontrib><creatorcontrib>Cannas, MDolores</creatorcontrib><creatorcontrib>Vascellari, Sarah</creatorcontrib><creatorcontrib>Abete, Claudia</creatorcontrib><creatorcontrib>Mandas, Antonella</creatorcontrib><creatorcontrib>Angius, Fabrizio</creatorcontrib><creatorcontrib>Cocco, Pierluigi</creatorcontrib><creatorcontrib>La Colla, Paolo</creatorcontrib><creatorcontrib>Dessi', Sandra</creatorcontrib><creatorcontrib>Pani, Alessandra</creatorcontrib><title>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</title><title>The open conference proceedings journal</title><description>It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection.</description><issn>2210-2892</issn><issn>2210-2892</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNTbsKAjEQDKKgqF9gk85KTXJ36pUiPhrhQLGVcOxpJJfVbCz8e3NgYeky7M4MwyxjIymmSi7SmVJSqGWuhBQRcWVpi_Uad9LY7R_eZUOiu4iT5CpP0h47Fzfta12ixasp-fqGFiiAR8v3WANS0GSIr6oKykC88AYd34EDr0NDjeOaH99RXw2F2HDQLooB61TaEgy_t8_G281pvZ88PD5f8cOlNlSCtdoBvuiSSykzMc9k8n_yA0c1TGQ</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Orru, Christina D</creator><creator>Cannas, MDolores</creator><creator>Vascellari, Sarah</creator><creator>Abete, Claudia</creator><creator>Mandas, Antonella</creator><creator>Angius, Fabrizio</creator><creator>Cocco, Pierluigi</creator><creator>La Colla, Paolo</creator><creator>Dessi', Sandra</creator><creator>Pani, Alessandra</creator><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20100101</creationdate><title>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</title><author>Orru, Christina D ; Cannas, MDolores ; Vascellari, Sarah ; Abete, Claudia ; Mandas, Antonella ; Angius, Fabrizio ; Cocco, Pierluigi ; La Colla, Paolo ; Dessi', Sandra ; Pani, Alessandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_9111506513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Orru, Christina D</creatorcontrib><creatorcontrib>Cannas, MDolores</creatorcontrib><creatorcontrib>Vascellari, Sarah</creatorcontrib><creatorcontrib>Abete, Claudia</creatorcontrib><creatorcontrib>Mandas, Antonella</creatorcontrib><creatorcontrib>Angius, Fabrizio</creatorcontrib><creatorcontrib>Cocco, Pierluigi</creatorcontrib><creatorcontrib>La Colla, Paolo</creatorcontrib><creatorcontrib>Dessi', Sandra</creatorcontrib><creatorcontrib>Pani, Alessandra</creatorcontrib><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The open conference proceedings journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Orru, Christina D</au><au>Cannas, MDolores</au><au>Vascellari, Sarah</au><au>Abete, Claudia</au><au>Mandas, Antonella</au><au>Angius, Fabrizio</au><au>Cocco, Pierluigi</au><au>La Colla, Paolo</au><au>Dessi', Sandra</au><au>Pani, Alessandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</atitle><jtitle>The open conference proceedings journal</jtitle><date>2010-01-01</date><risdate>2010</risdate><volume>1</volume><spage>54</spage><epage>60</epage><pages>54-60</pages><issn>2210-2892</issn><eissn>2210-2892</eissn><abstract>It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection.</abstract><doi>10.2174/2210289201001010054</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2210-2892 |
ispartof | The open conference proceedings journal, 2010-01, Vol.1, p.54-60 |
issn | 2210-2892 2210-2892 |
language | eng |
recordid | cdi_proquest_miscellaneous_911150651 |
source | Free E-Journal (出版社公開部分のみ) |
title | Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacologic%20Cholesterol%20Homeostasis%20Affects%20Prion%20Generation%20in%20a%20Synergistic%20Manner&rft.jtitle=The%20open%20conference%20proceedings%20journal&rft.au=Orru,%20Christina%20D&rft.date=2010-01-01&rft.volume=1&rft.spage=54&rft.epage=60&rft.pages=54-60&rft.issn=2210-2892&rft.eissn=2210-2892&rft_id=info:doi/10.2174/2210289201001010054&rft_dat=%3Cproquest%3E911150651%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=911150651&rft_id=info:pmid/&rfr_iscdi=true |